Nitric Acid

Nitric Acid

SCHEMBL18316488

O=C(O)[C@H](Cc1ccc(O)cc1)N[N+](=O)[O-].O=NO.O=[N+]([O-])O

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ERG11

The experimentally established mechanism targets of Nitric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
NAALAD2 Q9Y3Q0 1/20 0.48
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
FOLH1 Q04609 1/20 0.45
CA1 P00915 3/20 0.43
CA2 P00918 3/20 0.43
MME P08473 5/20 0.42
SLC7A5 Q01650 1/20 0.42
ACE P12821 6/20 0.41
CPA1 P15085 1/20 0.41
ACE2 Q9BYF1 1/20 0.41
CA12 O43570 1/20 0.38
CA9 Q16790 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL38173 0.92 FOLH1 (0.51) NAALAD2MEN1KMT2AL3MBTL1FOLH1
SCHEMBL38174 0.92 FOLH1 (0.51) NAALAD2MEN1KMT2AL3MBTL1FOLH1
Tyrosine SCHEMBL18045291 0.84 SLC7A5 (0.65) NAALAD2MEN1KMT2AL3MBTL1FOLH1
Tyrosine SCHEMBL18045293 0.84 SLC7A5 (0.65) NAALAD2MEN1KMT2AL3MBTL1FOLH1
SCHEMBL8642868 0.82 CA2 (0.44) NAALAD2MEN1KMT2AL3MBTL1FOLH1
Tyrosine SCHEMBL28280041 0.81 SLC7A5 (0.60) MMESLC7A5ACE
Tyrosine SCHEMBL28280042 0.81 SLC7A5 (0.60) MMESLC7A5ACE
SCHEMBL93588 0.79 CPA1 (0.54) NAALAD2L3MBTL1MMECPA1
SCHEMBL414333 0.79 CPA1 (0.54) NAALAD2L3MBTL1MMECPA1
SCHEMBL93589 0.79 CPA1 (0.54) NAALAD2L3MBTL1MMECPA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108135964-B Glutathione formulations and methods of use 分子防御公司 2023-02-17 CN disclosed
CN-108135964-A Glutathione preparation and application method 分子防御公司 2018-06-08 CN disclosed
EP-3310374-A1 GLUTATHIONE FORMULATION AND METHOD OF USE Molecular Defenses Corporation (US) 2018-04-25 EP disclosed
US-9901611-B2 Glutathione formulation and method of use Molecular Defenses Corporation (US) 2018-02-27 US disclosed
US-20160367620-A1 GLUTATHIONE DEMOPOULOS HARRY B (US) 2016-12-22 US disclosed
US-20160367621-A1 GLUTATHIONE FORMULATION AND METHOD OF USE Molecular Defenses Corporation 2016-12-22 US disclosed
WO-2016205804-A1 GLUTATHIONE FORMULATION AND METHOD OF USE Molecular Defenses Corporation (US) 2016-12-22 WO disclosed